TP53 and Diamond-Blackfan anemia: While it has been speculated that the hematopoietic phenotype at least in DBA patients is linked to the activation of the p53 tumor suppressor [11], the mechanistic understanding of the pathophysiology underlying DBA and other diseases linked to mutations affecting the ribosome remains incompletely understood.